• Oleic Acid C18:1(9Z) Workflow Guide

  2026-08-29

  Build reproducible hepatocyte lipid-loading, signaling, and inflammation assays with Oleic Acid (C18:1(9Z)). This guide translates a hepatic ischemia-reperfusion study into practical controls, preparation steps, mechanistic readouts, and troubleshooting strategies.

• Dabigatran for Thromboembolism: Evidence and Limits

  2026-08-28

  The reference review explains how dabigatran, an oral direct thrombin inhibitor, changed prevention and treatment strategies for thromboembolic disease by combining predictable pharmacokinetics with effective protection against stroke and recurrent venous thromboembolism. Its practical value lies in clarifying where fixed-dose non-vitamin K anticoagulation can replace warfarin, while also emphasizing renal function, bleeding management, and limits to transferring anticoagulation evidence into rhythm-control research.

• Aurora A Overexpression in Retinoblastoma

  2026-08-28

  This 2024 study identifies Aurora kinase A as a frequently elevated and functionally relevant vulnerability in human retinoblastoma. By integrating patient-tissue analysis with genetic, pharmacologic, cell-based, and xenograft experiments, the work connects AURKA expression with histopathologic high-risk features and provides a rationale for disease-specific targeted therapy.

• 3D Electrophysiology of Cardiac Organoids

  2026-08-27

  The reference study introduces shape-adaptive shell microelectrode arrays that wrap cardiac organoids and resolve electrical activity across their three-dimensional geometry. By combining field-potential mapping, calcium imaging, and pharmacological perturbation, the platform supports longitudinal analysis of conduction and repolarization in models relevant to cardiac disease and drug research.

• TPA: ERK/MAPK Activation and Research Use

  2026-08-27

  12-O-tetradecanoyl phorbol-13-acetate (TPA) is a phorbol ester that activates protein kinase C and can increase ERK/MAPK signaling. Its validated uses include signal transduction research, biochemical kinase assays, and mouse skin cancer models, while its insolubility in water requires solvent and storage control.

• Mildronate Lipidoids for Safer mRNA Delivery

  2026-08-26

  The ACS Nano study developed mildronate-derived cationic lipidoids that enabled efficient mRNA delivery with less local inflammation than an SM-102-based comparator. In prophylactic and therapeutic B16OVA melanoma models, the optimized mLNP-69 formulation supported effective cancer vaccination, highlighting low lipid dose and tolerability as linked design goals.

• Cepharanthine in Endometriosis: Organoid Evidence

  2026-08-25

  A 2026 study evaluates Cepharanthine across endometriotic stromal cells, patient-derived endometrial organoids, and a murine peritoneal model. Its main contribution is a translational mechanism linking reduced lesion growth with G0/G1 arrest, DNA-damage accumulation, impaired repair signaling, and mitochondrial apoptosis.

• Phenacetin in Human Organoid Pharmacokinetics

  2026-08-25

  Phenacetin can serve as a carefully controlled research compound for connecting chemical exposure, intestinal metabolism, transporter activity, and human-relevant pharmacokinetic modeling. This article examines how N-(4-ethoxyphenyl)acetamide fits into hiPSC-derived intestinal organoid workflows, where it adds value, and which limitations translational researchers must manage.

• ABT-199 (Venetoclax): Precision Beyond BCL-2

  2026-08-24

  ABT-199, also known as Venetoclax or GDC-0199, offers a precise way to interrogate BCL-2-dependent survival through the mitochondrial apoptosis pathway. This thought-leadership perspective connects its established value in hematologic malignancy models with emerging questions about senescent and disease-associated microglia in aged white matter, while separating evidence-backed conclusions from forward-looking translational hypotheses.

• Fasudil (HA-1077) HCl for Reliable Cell Assays

  2026-08-24

  This scenario-based guide explains how Fasudil (HA-1077) HCl, SKU A5734, can support reproducible ROCK-pathway experiments involving cell viability, proliferation, migration, and apoptosis. It connects product chemistry and handling data with practical dose-response design, orthogonal readouts, and evidence-based vendor selection.

• SAR405: Vps34 Control Under Energy Stress

  2026-08-23

  SAR405 is a selective Vps34 inhibitor for dissecting autophagy, phosphoinositide signaling, and vesicle trafficking under nutrient or energy stress. This article connects Vps34 pharmacology with new evidence that AMPK can restrain ULK1-dependent autophagy, providing a framework for more interpretable cellular assays.

• ML216 BLM Helicase Inhibitor: Applied Workflows

  2026-08-22

  Build enzyme, cell-based, and synthetic-lethality experiments around ML216 without confusing BLM targeting with broader RecQ helicase biology. This guide pairs practical dosing, controls, readouts, and troubleshooting with evidence from DNA-repair research.

• E-4031: A Precision Probe for Cardiac Risk

  2026-08-22

  E-4031 is more than a catalog reagent: it is a mechanistically defined hERG/IKr perturbation for linking ion-channel inhibition to QT interval prolongation, repolarization heterogeneity, and torsades de pointes risk in increasingly complex cardiac models.

• PTT and CD47 Blockade in Oral Cancer

  2026-08-21

  A 2026 study shows that photothermal therapy (PTT) strengthens CD47 blockade in oral squamous cell carcinoma by generating a calreticulin-dependent “eat me” signal and reducing extracellular matrix barriers to macrophage access. The findings provide a mechanistic framework for combining tumor-priming treatment with macrophage-directed immunotherapy rather than relying on CD47 inhibition alone.

• HCAR3 Cryo-EM Structures Reveal Agonist Selectivity

  2026-08-20

  Ye et al. combine cryo-EM structures of HCAR3-Gi and HCAR2-Gi complexes with cellular cAMP assays to define how agonists recognize these metabolite-sensing receptors. The study identifies pocket geometry and residue-specific aromatic interactions that help explain ligand preference, providing a structural framework for lipid metabolism regulation and HCAR3-focused drug discovery.

7922 records 1/529 page Next 12345 下5页 Last page